NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch. (2021)

First Author: O'Cathail SM
Attributed to:  Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/antiox10091380

PubMed Identifier: 34573012

Publication URI: http://europepmc.org/abstract/MED/34573012

Type: Journal Article/Review

Volume: 10

Parent Publication: Antioxidants (Basel, Switzerland)

Issue: 9

ISSN: 2076-3921